A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response
Author(s):
Roeland Lameris, Adam Shahine, Daniel G. Pellicci, Adam P. Uldrich, Stephanie Gras, Jérôme Le Nours, Richard W.J. Groen, Jana Vree, Scott J.J. Reddiex, Sergio M. Quiñones-Parra, Stewart K. Richardson, Amy R. Howell, Sonja Zweegman, Dale I. Godfrey, Tanja D. de Gruijl, Jamie Rossjohn, Hans J. van der Vliet
Details:
Nature Cancer, Volume 1, Issue 11, 2020-11-01
Article Link: Click here
Affiliations:
- University of Melbourne
- Monash University
- Vrije Universiteit Amsterdam
- University of Connecticut
- Royal Children's Hospital, Melbourne
- Cardiff University School of Medicine
- Department of Microbiology & Immunology
- Department of Molecular Biology
- Lava Therapeutics

